Learn More
This analysis was carried out to assess quantitative and qualitative relationships between animal and human toxicology data with anticancer drugs. Among 21 chemotherapeutic agents, one-sixth LD10 in the mouse or one-third toxic dose low (TDL) in the dog corresponded to acceptable doses in man when experimental and clinical data were obtained at identical(More)
1) 3-Acetyl pyridine has been found to be quite toxic when administered to mice. Simultaneous administration of nicotinamide or DPN protects against the toxicity of acetyl pyridine. Nicotinic acid and tryptophan do not protect animals from the lethal effects of the compound. 2) Nicotinamide inhibits the formation of the 3-acetyl pyridine analog of DPN from(More)
SUMMARY The antigenicity of several well established Moloney virus-induced transplantable leukemias was studied. Resistance was developed by pretreatment of isologous mice with x-radiated tumor tissue. In general, the neoplasms grew more rapidly in pre-irradiated mice (400 r) than in normal mice, and at low inoculum concentrations a higher percentage of(More)
A state of relative resistance against the transplantation of isografts of leukemias induced by the Rauscher virus (RV) was developed in HALB/*' an(l CDFi mice by pretreatment with X-irradiated tumor cells. In mice pretreated with cells from 1 tumor, significant cross-protection was obtained for all other RV-induced tumors tested and for some tumors induced(More)
Because the antigenic changes occurring after in vivo treatment of murine lymphoma cells with 5-(3,3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide (DTIC) were suggested to result from DTIC-induced somatic mutation(s), quinacrine dihydrochloride, an antimutagenic compound, was tested for possible antagonistic activity related to this phenomenon. The(More)
Graded doses of Cyclophosphamide (Cy) or 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) were given to CD2F1 or C57Bl/6 mice. One, 45 or 60 days later the animals were tested for allograft responses, competence of producing cytotoxic lymphocytes in vitro and lethal graft-versus-host disease (GVHD) in vivo, delayed-type hypersensitivity (DTH) and(More)